Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2 | P10415 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | AHR | P35869 | 2/20 | 0.38 |
| ▸ | CDK2 | P24941 | 3/20 | 0.38 |
| ▸ | CCNB2 | O95067 | 2/20 | 0.38 |
| ▸ | CCNE2 | O96020 | 2/20 | 0.38 |
| ▸ | CDK1 | P06493 | 2/20 | 0.38 |
| ▸ | CDK4 | P11802 | 2/20 | 0.38 |
| ▸ | CCNB1 | P14635 | 2/20 | 0.38 |
| ▸ | CCND1 | P24385 | 2/20 | 0.38 |
| ▸ | CCNE1 | P24864 | 2/20 | 0.38 |
| ▸ | CCNB3 | Q8WWL7 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13616029 | 1.00 | BCL2 (0.44) | BCL2MEN1KMT2ARXFP1CYP2A6 | |
| SCHEMBL13616027 | 1.00 | BCL2 (0.44) | BCL2MEN1KMT2ARXFP1CYP2A6 | |
| SCHEMBL19396968 | 1.00 | BCL2 (0.44) | BCL2MEN1KMT2ARXFP1CYP2A6 | |
| SCHEMBL13616024 | 1.00 | BCL2 (0.44) | BCL2MEN1KMT2ARXFP1CYP2A6 | |
| SCHEMBL19396754 | 0.98 | MEN1 (0.46) | BCL2MEN1KMT2ARXFP1CYP2A6 | |
| SCHEMBL21176157 | 0.95 | MEN1 (0.47) | BCL2MEN1KMT2ARXFP1CYP2A6 | |
| SCHEMBL13616030 | 0.89 | BCL2 (0.45) | BCL2MEN1KMT2ARXFP1CYP2A6 | |
| SCHEMBL16076434 | 0.87 | MEN1 (0.52) | MEN1KMT2ARXFP1CYP2A6ALDH1A1 | |
| SCHEMBL21764548 | 0.87 | MEN1 (0.52) | MEN1KMT2ARXFP1CYP2A6ALDH1A1 | |
| SCHEMBL21636087 | 0.87 | MEN1 (0.52) | MEN1KMT2ARXFP1CYP2A6ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190165279-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | JNC CORPORATION (JP) | 2019-05-30 | — | — | US | disclosed |
| US-20090273278-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-11-05 | — | — | US | disclosed |
| US-20090273278-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-11-05 | — | — | US | disclosed |
| EP-2112214-A1 | Dibenzo[g,p]chrysene derivatives and organic electroluminescent device using the same | Gracel Display Inc. (KR) | 2009-10-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190165279-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | TCF4, LGR4, OR51E2 | BCL2 2851/4885MEN1 1168/4885KMT2A 2057/4885 |
| US-20090273278-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OCIAD1, OCIAD2, ORMDL3 | BCL2 2348/4885MEN1 3925/4885KMT2A 3177/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.